Rohan Dharmakumar News Today

A beta blocker typically used to treat heart problems, hemangioma, migraines and anxiety could be a new therapeutic for patients with sickle cell disease.

A beta blocker typically used to treat heart problems, hemangioma, migraines and anxiety could be a new therapeutic for patients with sickle cell disease. Researchers led by Ankit A. Desai, MD, associate professor of medicine at the Krannert Cardiovascular Research Center (KCVRC) at Indiana University School of Medicine, have been awarded a $3 million grant by the U.S. Department of Defense to evaluate the efficacy of this drug.

Identifying four stages of heart attack expected to improve patient outcomes

In a consensus statement, the Canadian Cardiovascular Society defines four stages of acute atherothrombotic myocardial infarction based on tissue injury severity.

The Canadian Cardiovascular Society (CCS) released the world's first classification of acute myocardial infarction (AMI), or heart attack, based on heart tissue damage research that was driven by two cardiovascular investigators within the Ischemic Heart Disease Program of Krannert Cardiovascular Research Center (KCVRC) at Indiana University School of Medicine and Northern Ontario School of Medicine.

A multi-institution study led by Rohan Dharmakumar, PhD, of Indiana University School of Medicine, has identified that iron drives the formation of fatty tissue in the heart and leads to chronic heart failure in about fifty percent of heart...

A multi-institution study led by Rohan Dharmakumar, PhD, of Indiana University School of Medicine, has identified that iron drives the formation of fatty tissue in the heart and leads to chronic heart failure in about fifty percent of heart attack survivors.

A study published in the Journal of the American College of Cardiology and conducted by researchers from the Indiana University School of Medicine has found that standard treatment methods used [...]

A study led by Indiana University School of Medicine is challenging standard treatment methods used to prevent muscle damage during heart attack. In a

Intramyocardial hemorrhage could be a major cause of reperfusion injury after MI and contribute to myocardial damage, a new study has found, giving new leads for therapeutic intervention.